Page results
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
A large trial at UCLH is looking to optimise chemotherapy for young people with nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023.
-
Young cancer patients and staff couldn’t believe their eyes when David Beckham paid a visit to the University College Hospital Macmillan Cancer Centre earlier this year.
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
-
UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.
-
Research published in the latest issue of the Journal of Medical Genetics concludes that regularly monitoring women who carry BRCA gene alterations does provide some benefits.
-
UCLH will play a vital role in a new respiratory virus study.
File results
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0424 - Ectopic pregnancies
-
FOI/2024/0431 - Hospital patient monitoring system on wards
-
FOI/2024/0444 - Protocols for titanium/ titanium alloy clips to repair ruptured brain aneurysms
-
FOI/2024/0445 - Framework agency spend for locum doctors for February to March 2024
-
FOI/2024/0535 - Agency spend, providers and department contacts for locums by specialities and sites
-
FOI/2024/0537 - SHO doctor shifts covered by physician associates December 2023-May 2024
-
FOI/2024/0554 - Robotic Process Automation (RPA) Programme
-
FOI/2024/0550 - Syntometrine vs Misoprostol/ treatment uses for post-partum haemorrhage